Eledon Pharmaceuticals (ELDN) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -515.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -515.58% |
| Dec 31, 2025 | -146.31% |
| Sep 30, 2025 | -2.72% |
| Jun 30, 2025 | 73.45% |
| Mar 31, 2025 | 69.22% |
| Dec 31, 2024 | 159.35% |
| Sep 30, 2024 | -40.23% |
| Jun 30, 2024 | -276.99% |
| Mar 31, 2024 | -75.47% |
| Dec 31, 2023 | 114.03% |
| Sep 30, 2023 | -6.94% |
| Jun 30, 2023 | -11.97% |
| Mar 31, 2023 | -12.63% |
| Dec 31, 2022 | -306.68% |
| Sep 30, 2022 | -6.66% |
| Jun 30, 2022 | -25.23% |
| Mar 31, 2022 | -16.06% |
| Dec 31, 2021 | 534.53% |
| Sep 30, 2021 | -59.78% |
| Jun 30, 2021 | -185.54% |
| Mar 31, 2021 | -3.94% |
| Dec 31, 2020 | -56.01% |
| Sep 30, 2020 | -110.41% |
| Jun 30, 2020 | 36.76% |
| Mar 31, 2020 | -67.73% |
| Dec 31, 2019 | 8.96% |
| Sep 30, 2019 | 16.55% |
| Jun 30, 2019 | -28.22% |
| Mar 31, 2019 | -74.42% |
| Dec 31, 2018 | -117.43% |
| Sep 30, 2018 | -18.01% |
| Jun 30, 2018 | 52.16% |
| Mar 31, 2018 | -105.67% |
| Dec 31, 2017 | 43.67% |
| Sep 30, 2017 | -87.78% |
| Jun 30, 2017 | -654.93% |
| Mar 31, 2017 | 88.11% |
| Dec 31, 2016 | 66.08% |
| Sep 30, 2016 | 86.68% |
| Jun 30, 2016 | 90.14% |
| Mar 31, 2016 | 13.83% |
| Dec 31, 2015 | -77.46% |
| Sep 30, 2015 | -85.49% |
| Jun 30, 2015 | -53.08% |
| Mar 31, 2015 | -173.57% |
| Dec 31, 2014 | -12.06% |
| Sep 30, 2014 | -89.90% |